****** PLEASE NOTE ABOVE MESSAGE ABOUT TRANSITION OF EMPLOYMENT. THIS SHOULD BE A SEEMLESS MOVE FOR PATIENTS BUT ANY ISSUES PLEASE CONTACT ME DIRECTLY ******
Dr. Srihari S. Naidu is a nationally-recognized academic interventional cardiologist and Director of Interventional Innovation and Director of the Hypertrophic Cardiomyopathy Program - with offices in Long Island and Westchester - at Westchester Medical Center.
Dr. Naidu's areas of expertise include hypertrophic cardiomyopathy and alcohol septal ablation, angioplasty and stent placement, aortic and mitral valvuloplasty (and mitral repair - Mitraclip), ASD/PFO closure, and percutaneous ventricular assist device placement for high-risk angioplasty and heart failure.
Involved in guiding the interventional cardiology field at the national level, Dr. Naidu is Founder and Past Chair of the Emerging Leader Mentorship (ELM) Program (www.scai.org/ELM) run by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC) and Cardiovascular Research Foundation (CRF), is a two-term nationally-appointed representative to the ACC Interventional Scientific Council, and a member of the American College of Cardiology's Curriculum Development Work Group. He is also Co-Chair of the Development Committee for the Society for Cardiovascular Angiography and Interventions.
He is also an Associate Director of TCT, the largest interventional cardiology professional conference, where he helps run the Hypertrophic Cardiomyopathy and Alcohol Septal Ablation technique-training session. He is a Past Trustee of the Society for Cardiovascular Angiography and Interventions (SCAI), and Editor of the Textbook Hypertrophic Cardiomyopathy.